Saturday 17 October 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024. In the quarter to June 2026, revenue grew 33.7%, EPS grew 868.0% and free cash flow grew 35.5%, each against the same quarter a year earlier.

295.54 2.96 −0.99%

Follow LGND

Alert me

Market cap: $6.0B
P/E: 29.5×
Fwd P/E: 54.7×
Dividend yield: —
F-score: 6/9
Altman Z: 5.45
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	5.42%	13.47%	17.13%	21.96%
Piotroski F-Score Full definition →		5	6	6	5
ROA Full definition →		4.00%	9.95%	12.60%	12.58%
ROIC Full definition →		1.52%	3.62%	9.06%	8.19%
Return on Tangible Assets Full definition →		6.68%	15.66%	18.62%	13.98%
Average Days of Receivables Full definition →		84.40	83.12	72.87	87.84
Free Cash Flow per Share Full definition →		0.62	3.15	6.77	7.15
Free Cash Flow Full definition →		12.13	60.91	134.59	143.37
Capital Expenditures Full definition →		(19.79)	11.56	11.09	11.65
Other line items
Cash ROIC Full definition →		0.59%	2.74%	6.02%	4.14%
Accounts Receivable Turnover Full definition →		5.01	5.18	5.62	4.75
Accounts Payable Turnover Full definition →		3.44	3.44	2.44	1.48
Inventory Turnover Full definition →		1.01	1.25	0.93	1.03
Average Days of Payables Full definition →		93.29	81.23	148.10	258.50
Days of Inventory on Hand Full definition →		301.76	228.95	373.24	282.08
Tax Rate Full definition →		(0.23)	(0.22)	(0.17)	(0.17)
Research and Development Expense of Revenue Full definition →		32.68%	30.28%	12.11%	14.23%
Selling, General and Administrative Expense of Revenue Full definition →		37.03%	34.48%	34.42%	35.60%
Share Based Compensation of Revenue Full definition →		15.96%	17.48%	18.07%	18.33%
Interest Coverage Full definition →		4.59	8.70	16.91	15.30
Operating CF/Net income Full definition →		0.66	0.40	0.80	0.67
Depreciation/Fixed assets Full definition →		9.09	0.00	0.00	0.00
Capex/Depreciation Full definition →		(0.63)	0.38	0.38	0.40
Revenue per Share Full definition →		12.83	13.86	13.80	14.48
Operating CF per Share Full definition →		1.63	2.55	6.21	6.57
Capex per Share Full definition →		(1.01)	0.60	0.56	0.58
Capex to Sales Full definition →		0.08	(0.04)	(0.04)	(0.04)

Show all line items

Columns are period end dates

Stockrow Weekly